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1. Introduction
   Throughout the centuries humans have relied substantially 
on natural products to treat a variety of diseases and natural 
agents represent a continuing source for novel drug discovery[1]. 
According to an estimation made by World Health Organization, 
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Objective: To investigat the mechanism of antitumor efficacy of Origanum dayi (O. dayi) and 
Ochradenus baccatus (O. baccatus) extracts by exploring apoptosis-inducing potential. 
Methods: The aqueous extracts of aerial parts of aforementioned plants were prepared and 
used for this study. HepG2 cells were treated with varying concentrations (0, 2 and 5 mg/mL) 
of each plant extract for 24 or 48 h. Cell apoptosis was measured by annexin V-fluorescein 
isothiocyanate binding assay and flow cytometry. The expression levels of various apoptosis-
related genes were determined by semi-quantitative reverse transcription-polymerase chain 
reaction. 
Results: O. dayi and O. baccatus extracts exerted apoptotic effects on HepG2 cells for 48 h 
following treatment. O. dayi extract was found to be a better apoptosis-inducing agent than O. 
baccatus extract as the former delivered greater efficacy at a lower concentration. Both extracts 
manifested upregulation of Bax, Bad, cytochrome c, caspase-3, caspase-7, caspase-9 and poly 
(adenosine diphosphate-ribose) polymerase. 
Conclusions: The aqueous extracts of O. dayi and O. baccatus are capable of inducing 
apoptosis in HepG2 cells through modulation of mitochondrial pathway which explains their 
antitumor activities. These desert plants may serve as useful resources to develop effective 
remedies for hepatocellular carcinoma and other human malignancies. 
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currently 65% of the World’s population relies primarily on 
traditional medicines derived from plants for primary health care 
need[2]. Traditional medicinal plants have been used in treating 
cancer for several millennia in several parts of the globe and herbal 
medicines alone or in combination with conventional therapeutics 
are currently being used for cancer treatment worldwide[3-6]. Plant-
derived natural products represent a rich source for the discovery and 
development of anticancer drugs[2,7,8]. Approximately, 80% of all 
drugs approved by the United States Food and Drug Administration 
during the last three decades (1981-2010) for cancer therapy are 
either natural products per se or are based on naturally occurring 
molecules[9]. With the advent and refinement of new technologies, 
such as genetic techniques for production of secondary plant 
metabolites, combinatorial synthesis and high-throughput screening, 
it is expected that novel compounds from medicinal plants would be 
identified and developed as safe and effective anticancer drugs.
   Plants growing under adverse environmental conditions, such as 
low nutrient soils, scarcity of water, extreme temperature and strong 
solar radiation, have developed unique defense system to survive. 
Phytochemicals (secondary metabolites) endowed with remarkable 
bioactivities, such as antioxidant, anti-inflammatory, antimutagenic, 
antiviral, antifungal and antimicrobial properties, represent plant 
defense systems[10-13]. Desert plant phytochemicals that protect 
these plants against various stressful environmental conditions 
may also be effective in preventing and combating adverse 
pathophysiological anomalies and complex diseases, including 
cancer. A large number of in vitro and in vivo studies have provided 
substantial evidence that botanical extracts as well as isolated 
phytocompounds derived from plants of desert and semidesert 
habitats exert potent oncosuppressive and anticancer activities[13-
15].
   Although numerous desert plants have been studied for their 
antitumor properties, it is likely that a large number of plants 
from desert origin are not used for systematic evaluation of their 
phytoconstituents as potential anticancer agents. Accordingly, 
we have initiated a comprehensive research program to screen 
antitumor activities of previously unexplored desert plants. The 
aqueous extracts of aerial parts of several desert plants, namely 
Achillea fragrantissima (Forssk.) Sch. Bip. (Compositae), 
Ochradenus baccatus Delile (Resedaceae) (O. baccatus), Origanum 
dayi Post (Lamiaceae) (O. dayi), Phlomis platystegia Post 
(Lamiaceae), and Varthemia iphionoides Boiss (Compositae), were 
prepared and tested against an in vitro tumor model utilizing HepG2 
human hepatocellular carcinoma cell line. According to our recent 
communication[16], O. dayi extract exhibited a substantial cytotoxic 
effect against HepG2 cells followed by O. baccatus following 24 
h exposure with the plant material. Our results also indicated that 
all plant extracts displayed antiproliferative effect following 48 h 
exposure. However, a substantial effect was observed with O. dayi 
followed by O. baccatus[16]. In spite of encouraging antitumor 
effects of the aqueous extracts of O. dayi and O. baccatus, the 
underlying molecular mechanisms are not understood. Hence, the 
objective of the present study was to investigate the mechanism 
of anticancer efficacy of O. dayi and O. baccatus by exploring 
apoptosis-inducing potential of these plant extracts using HepG2 
human hepatocellular carcinoma cells. To the best of our knowledge 
and belief, this is the first study investigating the cellular and 
molecular mechanisms of anticancer effects of O. dayi and O. 
baccatus.
2. Materials and methods
2.1. Preparation of plant aqueous extracts
   The aqueous extracts of freshly collected aerial parts of O. baccatus 
and O. dayi were prepared according to our previously published 
method[16]. The extracts were stored at 4°C in a refrigerator and 
subsequently used for various assays as indicated below. 
2.2. Cell culture 
   HepG2 cells were purchased from the American Tissue Culture 
Collection (Manassas, VA) and grown in Dulbecco’s Modified 
Eagle’s Medium (Sigma-Aldrich, St. Louis, MO) supplemented with 
10% fetal bovine serum, 100 units/mL penicillin, and 100 μg/mL 
streptomycin (all purchased from HyClone, Logan, UT). HepG2 cells 
were incubated in a humidified incubator (NAPCO Series 8 000 WJ, 
ThermoFisher Scientific, Waltham, MA) at 37 °C under an atmosphere 
containing 5% CO2. The cells were subcultured at preconfluent 
densities using 0.25% trypsin-EDTA (Millipore, Phillipsburg, NJ).  
2.3. Apoptosis assay by flow cytometry
   Apoptosis in HepG2 cells was detected using annexin V-fluorescein 
isothiocyanate (FITC)/propidium iodide (PI) apoptosis detection kit 
(Biolegend, San Diego, CA) following the manufacturer’s instruction. 
Briefly, cells were plated into 6-well culture dishes (3×105 cells/well) 
for 24 h prior to the addition of plant extracts (0, 2 or 5 mg/mL). 
Following 24 or 48 h incubation with the extract, the percentage of 
apoptotic cells was determined by the annexin V-FITC/PI assay. The 
cells were harvested, washed with cold phosphate-buffered saline and 
resuspended in binding buffer. The cells were treated with annexin 
V-FITC conjugate and incubated for 15 min at room temperature in 
the dark condition.  The cells were then stained with PI (5 μg/mL) and 
analyzed by flow cytometry using a BD Accuri C6 software (Accuri® 
C6 Flow Cytometer, Ann Arbor, MI) within 1 h following the staining. 
The data acquisition and analysis were performed using BD Accuri 
C6 Flow software and a minimum of 10 000 cells per sample was 
analyzed and data stored in list mode. Electronic compensation was 
used to eliminate bleed through fluorescence. 
2.4. Gene expression assay
   Total RNA from HepG2 cells exposed to each plant extract for 
indicated time periods was extracted using Quick RNA miniPrep 
kit (Zymo Research, Irvine, CA) following the vendor’s protocol. 
Briefly, cells were plated into 6-well culture dishes (3×105 cells/well) 
for 24 h prior to the addition of plant extracts (0, 2 or 5 mg/mL). The 
expression levels of apoptosis-related genes were monitored by semi-
quantitative RT-PCR using the cDNA verso kit with a temperature scale 
of 42 °C for 30 min for RT, and 32 cycles of 94 °C for 30 second, 56 
°C for 30 second, and 72 °C for 30 second. The RT-PCR was carried 
out using the primers: BAX-F – 5’-AGG GGC CTT TTT GTT ACA 
GG-3’, BAX-R – 5’-ACG TCA GCA ATC ATC CTC TG-3’; BAD-F – 5’-
GAG CTG ACG TAC AGC GTT GA-3’, BAD-R – 5’-GGG TAG GGT GTG 
TGG AAA AC-3’; CASP3-F – 5’-AGG GTG CTA CGA TCC ACC AGC 
A-3’, CASP3-R – 5’-CCA TGG CTC TGC TCC GGC TC-3’; CASP7-F – 
5’-GCC ATG CCC AGG ACA AGC CA-3’, CASP7-R – 5’-GCA CGC CGG 
AGG ACA TGG TT-3’; PARP-F – 5’-CGA CAC GTT AGC GGA GCG 
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GAC-3’, PARP-R – 5’-GCG CCC GCT CTT AGC GTA CT-3’; CYT C-F 
– 5’-AGA CTC ACC CGT GCT TCA GT-3’, CYT C-R – 5’-ACT CCC 
AAT CAG GCA TGA AC-3’ and GAPDH-F – 5’-AGA CAG CCG CAT 
CTT CTT GT-3’; GAPDH-R – 5’-TAC TCA GCA CCA GCA TCA CC-3’. 
These primer sequences were designed utilizing the Primer3 online 
program and synthesized by Eurofins MWG Operon (Huntsville, 
AL). The PCR products were analyzed on 1% agarose gel and 
visualized by ethidium bromide staining. The GAPDH was used as the 
housekeeping gene.
3. Results 
   In this study, aqueous extracts of aerial parts of two desert 
plants (O. baccatus and O. dayi) were prepared and used for in 
vitro experiments. The HepG2 cells were exposed to varying 
concentrations of each plant extract for either 24 or 48 h and 
apoptosis was measured by annexin V-FITC/PI assay. The results are 
displayed in Figures 1 and 2. The addition of O. baccatus extract (at 
2 or 5 mg/mL) to the cell culture medium marginally induced cell 
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Figure 1. An aqueous extract of O. baccatus induces apoptosis of HepG2 cells. 
FL1-A: fluorescence 1 area; FL2-A: fluorescence 2 area.
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Figure 2. An aqueous extract of O. dayi induces apoptosis of HepG2 cells. 
FL1-A: fluorescence 1 area; FL2-A: fluorescence 2 area.
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killing effect following 24 h as compared to untreated cells (Figures 
1A-1C). Although the same extract at 2 mg/mL did not exhibit any 
apoptotic death following 48 h exposure compared to untreated 
cells (Figures 1D and 1E), the proportion of apoptotic cells were 
substantially elevated due to the extract treatment at 5 mg/mL at the 
same time point (48 h) compared to untreated cells (Figures 1D-1F). 
In the case of O. dayi, a slight increase in the percentage of apoptotic 
cells was noticed due to the extract treatment at 2 mg/mL as early 
as 24 h compared to untreated control cells (Figures 2A and 2B). 
However, the extract at 5 mg/mL was as not effective as the same 
at a lower concentration for the same time point study (Figure 2C). 
Interestingly, a marked increase in the proportion of apoptotic cells 
(63.3%) was observed with O. dayi extract at 2 mg/mL at 48 h post 
treatment in comparison with that of control cells (2.6%) (Figures 
2D and 2E). After 48 h, the higher concentration manifested less 
pronounced effect in terms of apoptosis induction (Figures 2D and 
2F).
   HepG2 cells exposed to O. baccatus and O. dayi extracts for 
various time periods were used to perform RT-PCR to determine 
expression of several apoptosis-related genes. As depicted in -s 3 
and 4, both plant extracts at (2 or 5 mg/mL) elevated the mRNA 
expression of BAX, BAD, CASP3, CASP7, CASP9, PARP and CYT C. A 
better result was noticed for most of the genes 48 h following each 
extract treatment compared to 24 h post-treatment.
Figure 3. An aqueous extract of O. baccatus alters the expression of 
apoptosis-related genes in HepG2 cells. 
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Figure 4. An aqueous extract of O. dayi alters the expression of apoptosis-
related genes in HepG2 cells. 
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4. Discussion
   Bioactive plant extracts are becoming useful resources to develop 
less toxic and more effective drugs to manage cancer progression. 
We have recently reported antitumor effects of extracts from several 
plants of desert origin. The most promising results were noticed 
with aqueous extracts of O. baccatus and O. dayi against HepG2 
human liver cancer cells[16]. Nevertheless, the mechanisms of such 
antitumor activities were not studied. Accordingly, the present 
work was initiated to probe into possible cellular and molecular 
mechanism of action of previously reported antiproliferative effects 
of these two desert plants.
   Apoptosis or programmed cell death, a highly structured and 
orchestrated process, plays an important role in regulating cell 
number for the growth and homeostasis of tissues by removing aged, 
damaged and unwanted cells. This self-destructive cellular process is 
critical for organ development, tissue remodeling, immune regulation 
and several disease conditions[17]. The homeostasis in eukaryotic 
cells is subjected to a delicate balance between survival and death 
signals originated from extracellular domain[18]. One of the salient 
characteristics of carcinogenesis is that the dividing tumor cells fail 
to initiate apoptosis following DNA damage[19]. Development of 
approaches that reinstall the apoptotic machinery selectively within 
tumor cells could be an effective measure of cancer control[20]. The 
primary mode of action of most anticancer drugs entails induction 
of apoptosis in neoplastic cells. Likewise, a large number of natural 
agents have shown promising anticancer or cancer preventive 
properties by induction of apoptotic pathways in transformed cells 
during process of carcinogenesis[21-24]. 
   Various techniques have been developed to detect apoptosis based 
on several events in the apoptotic process. One of the early events, 
cells which are undergoing apoptosis reorient phosphatidylserine 
from the inner side of the plasma membrane to its outer leaflet. 
Under this condition, cells can bind to annexin V and this process 
can be used as a marker of apoptosis[25]. In the present study, 
apoptosis in HepG2 cells exposed to O. baccatus and O. dayi 
extracts was determined by annexin V assay. Our results captured 
using annexin V staining showed that both O. baccatus and O. dayi 
plant extracts elicited apoptosis in HepG2 cells 48 h following the 
treatment with each plant material. The extent of apoptosis induction 
appears to be greater with O. dayi at 2 mg/m/L compared to that 
of O. baccatus. A higher concentration of extract of O. baccatus 
(5 mg/mL) was necessary to visualize any positive effect in terms 
of apoptosis induction. We previously observed a substantial 
antiproliferative effects of O. dayi followed by O. baccatus plant 
extract against HepG2 cells[16]. Taken together, we suggest that the 
antitumor effects O. dayi and O. baccatus plant extracts against 
HepG2 cells could be achieved, at least in part, by promotion of cell 
apoptosis.  
   The mechanisms of apoptosis predominantly involve two signaling 
pathways, namely mitochondrial (intrinsic) pathway and death 
receptor (extrinsic) pathway. The death receptor-mediated pathway 
engages Fas/FasL and other members of the tumor necrosis factor 
receptor family that activate caspase-8[26,27]. The mitochondrial 
pathway, implicated in the function of a majority of anticancer drugs, 
utilizes cytochrome c (cyt. c), apoptotic protease activating factor 1 
and caspase-9[28]. The mitochondrial apoptotic pathways is regulated 
by the Bcl-2 family proteins, including pro-apoptotic proteins, such 
as Bax, Bad and Bak, and anti-apoptotic proteins, namely Bcl-2, Bcl-
xL and Bcl-w[29,30]. The activation of Bax and inhibition of Bcl-2 
results in mitochondrial disruption and subsequent release of cyt. c 
through the outer mitochondrial membrane into the cytosol. Inside 
the cytosol, cyt. c associates with apoptotic protease activating factor 
1 and activates caspase-9 which, in turn, triggers the activation of 
caspase-3 and/or caspase-7[31,32]. The activated caspase-3 functions 
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as the key executioner of apoptosis and leads to the cleavage and 
inactivation of key cellular substrates, including poly (adenosine 
diphosphate-ribose) polymerase (PARP)[33]. The PARP, a 116 kDa 
DNA repair enzyme, is mostly activated by DNA strand breaks. 
The cleavage of PARP has been considered to be a key evidence 
of caspase-3 activation and apoptosis[34]. In the current study, we 
measured the expression of various mitochondrial apoptosis-related 
genes at transcriptional level. Our gene expression study indicates 
upregulation of Bax, Bad, cyt. c., caspase-3, caspase-7, caspase-9, 
and PARP. All these results suggest that O. dayi and O. baccatus 
bioactive phytoconstituents induce apoptosis in HepG2 cells through 
mechanisms involving mitochondria-dependent pathway. This is 
in line with results reported from our laboratory showing crucial 
role of mitochondrial apoptotic pathway in antitumor efficacy of 
various natural products in experimental hepatocarcinogenesis[35-
37]. Similar tumor cell growth inhibitory and proapoptotic activity 
via mitochondrial pathway has been observed with phytoconstituents 
present in an Australian desert tree Acacia victoriae (Bentham)[38]. 
   The identity of active phytochemicals responsible for the observed 
apoptosis-inducing effect is not known at the present time and 
requires additional experiment. Phytochemical analysis of the 
whole O. dayi plant yielded a large number of volatile constituents, 
including 1,8-cineole, α-terpineol, (E)-sabinene hydrate, (E)-
sabinene hydrate acetate, terpinen-4-ol and linalyl acetate[39]. Other 
investigators have identified various phytochemicals, including 
flavonoids (quercetin 3-O-β-glucosyl(1→2)-α-rhamnoside-7-O-α-
rhamnoside and quercetin 3-O-p-coumaryl(1→6)-β-glucosyl(1→6)-
β-glucoside-7-O-α rhamnoside), quercetin glycosides (quercetin 
3-gentiobioside, isoquercitrin and quercitrin) and kaempferol 
glycosides (astragalin and afzelin) in O. baccatus[40]. These 
compounds as well as components yet to be identified may be 
involved in antiproliferative and proapoptotic activities of two 
aforementioned desert plans. 
   In conclusion, the results derived from the present investigation 
show for the first time that aqueous extracts of two desert plants (O. 
dayi and O. baccatus) exert apoptosis (programmed cell death) in 
HepG2 human hepatocellular carcinoma cells. A treatment period 
of 48 h seems to be necessary to achieve an apoptosis-inducing 
effect. O. dayi extract emerges as a better apoptosis-inducing agent 
than O. baccatus extract as the former delivers greater efficacy at 
lower concentration. The mechanism of the proapoptotic effects of 
both plant materials involves mitochondria- and caspase-3-mediated 
pathway. All these results provide valuable mechanistic insight 
to the antitumor effects of O. dayi and O. baccatus as observed 
previously[16]. These encouraging preliminary data may facilitate 
the development of novel chemotherapeutic agents based on desert 
plant O. dayi and O. baccatus for the management of hepatocellular 
carcinoma and other difficult-to-treat and life threatening 
malignancies. 
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   The work is an interesting ethnopharmacological report. It provide 
new information on the property of desert plants and can be further 
applied for medical usage. 
  
Research frontiers
   This is a new experiment on the available species from deserts. 
This can highlight the advantage from locally available species for 
further implementation in actual medical usage in the future. 
Related reports
   This work contains new data. There are no previous reports on 
this specific topic. But there are some relating reports that have been 
cited and discussed in the paper. 
Innovations and breakthroughs
   This work gives new knowledge from experiment on locally 
available plants. It can be referencing papers in ethnopharmacology 
field. The work can be further referenced in the future publications. 
  
Applications
   The application in real medical usage is possible. The application 
in oncology and hepatology is possible. The work can be a further 
referencing work for the other research groups.     
Peer review
   The work is a good standard report on ethnopharmacology on 
the available plants species from deserts. The work contains new 
knowledge on the studied local species. The standard investigation 
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